Contributors

Aaron Lapat

Managing Partner
Bruce Rychlik

Managing Partner, Life Sciences
Erik Lundh

Managing Partner
Jesse Hershman

Partner
Jonathan Fortescue

Managing Partner
Park Square Executive Search
Stacey Lerner

Partner

Park Square Executive Search Archive

NFlection Therapeutics Appoints William Hodder as CEO and Expands Leadership Team to Accelerate Development of Targeted Treatments for Rare Diseases

Park Square Executive Search

October 18, 2021

https://www.passle.net/Content/Images/passle_logo-186px.png Passle https://passle.net

Park Square Executive Search

Park Square has placed William Hodder as Chief Executive Officer at NFlection Therapeutics, Inc.

NFlection Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for rare RASopathies, today announced that it has appointed William Hodder as CEO.

https://www.businesswire.com/news/home/20211018005225/en/NFlection-Therapeutics-Appoints-William-Hodder-as-CEO-and-Expands-Leadership-Team-to-Accelerate-Development-of-Targeted-Treatments-for-Rare-Diseases

unknownx500

More posts by Park Square Executive Search

Park Square Places Aldor Delp as Chief Executive Officer at ResNav Solutions

Park Square Places Aldor Delp as Chief Executive Officer at ResNav Solutions

Park Square Executive Search

Park Square Places Jamie Lewis as Chief Commercial Officer at Inflammatix

Park Square Places Jamie Lewis as Chief Commercial Officer at Inflammatix

Park Square Executive Search

Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO

Rubedo Life Sciences Appoints Former Allergan Executive and Biotechnology Veteran Dr. Frederick Beddingfield III as CEO

Park Square Executive Search

Park Square Places Nelson Azoulay as Senior Vice President of Strategy and Business Development at Flagship Pioneering

Park Square Places Nelson Azoulay as Senior Vice President of Strategy and Business Development at Flagship Pioneering

Park Square Executive Search

Executive Turnover Analysis - PE-backed SaaS

Executive Turnover Analysis - PE-backed SaaS

Park Square Executive Search

Recent posts from Park Square Executive Search

Life Sciences Quarterly Newsletter from Park Square Executive Search

Life Sciences Quarterly Newsletter from Park Square Executive Search

Erik Lundh

Time to update the list...

Time to update the list...

Aaron Lapat

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Deep Genomics Announces the Appointment of Brian O'Callaghan as CEO

Erik Lundh

Dr. Laura Carter joins Character Biosciences as CSO

Dr. Laura Carter joins Character Biosciences as CSO

Erik Lundh

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Sid Mukherjee, Lew Cantley behind new cancer biotech with food+drug combo treatment ambitions

Erik Lundh

repost cancel

As a free user, you can like posts.

To repost this post to your own Passle blog, you will need to upgrade your account.

For plans and pricing, please contact our sales team at sales@passle.net

Sorry, you don't have permission to repost or create posts.

cancel